Hostname: page-component-7c8c6479df-ws8qp Total loading time: 0 Render date: 2024-03-19T09:33:43.280Z Has data issue: false hasContentIssue false

Economic analysis of the implementation of autologous transfusion technologies throughout England

Published online by Cambridge University Press:  26 April 2005

Simon Dixon
Affiliation:
University of Sheffield
Virge James
Affiliation:
National Blood Service (Sheffield)
Daniel Hind
Affiliation:
University of Sheffield
Craig J. Currie
Affiliation:
University of Wales College of Medicine

Abstract

Objectives: This study aims to provide the first estimates of the costs and effects of the large scale introduction of autologous transfusion technologies into the United Kingdom National Health Service.

Methods: A model was constructed to allow disparate data sources to be combined to produce estimates of the scale, costs, and effects of introducing four interventions. The interventions considered were preparing patients for surgery (PPS) clinics, preoperative autologous donation (PAD), intraoperative cell salvage (ICS), and postoperative cell salvage (PoCS).

Results: The key determinants of cost per operation are the anticipated level of reductions in blood use, the mean level of blood use, mean length of stay, and the cost of the technology. The results show the potential for considerable reductions in blood use. The greatest reductions are anticipated to be through the use of PPS and ICS. Vascular surgery, transplant surgery, and cardiothoracic surgery appear to be the specialties that will benefit most from the technologies.

Conclusions: Several simplifications were used in the production of these estimates; consequently, caution should be used in their interpretation and use. Despite the drawbacks in the methods used in the study, the model shows the scale of the issue, the importance of gathering better data, and the form that data must take. Such preliminary modeling exercises are essential for rational policy development and to direct future research and discussion among stakeholders.

Type
RESEARCH REPORTS
Copyright
© 2005 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Claxton K, Neumann PJ, Araki S, Weinstein MC. 2001 Bayesian value-of-information analysis. An application to a policy model of Alzheimer's disease. Int J Technol Assess Health Care. 17: 3855.Google Scholar
Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. 1999 Transfusion medicine: Blood transfusion. N Engl J Med. 340: 438447.Google Scholar
Hill J. 2002. Trent cell salvage pilot study summary of cost data analysis. Sheffield: National Blood Service
Jefferies LC, Sachais BS, Young DS. 2001 Blood transfusion costs by diagnosis-related groups in 60 university hospitals in 1995. Transfusion. 41: 522529.Google Scholar
Mathoulin-Pelissier S, Salmi LR, Verret C, Demoures B. 2000 Blood transfusion in a random sample of hospitals in France. Transfusion. 40: 11401146.Google Scholar
Murphy MF, Edbury C, Wickenden C. 2002. Results of a questionnaire survey in relation to the implementation of the Health Services Circular 1998/224 ‘Better Blood Transfusion’. Available at: http://www.doh.gov.uk/bbt2/hscsurveyresults2002.doc. Accessed: July 25
National Blood Service. 2001. Blood matters. Issue 8. London: National Blood Service
Regan F, Taylor C. 2002 Blood transfusion medicine. BMJ. 325: 143147.Google Scholar
Sanguis Study Group. 1994 Use of blood products for elective surgery in 43 European hospitals. Transfus Med. 4: 251268.
Scottish Intercollegiate Guidelines Network. 2001. Perioperative blood transfusion for elective surgery. Edinburgh: Royal College of Physicians
Syrjala MT, Kytoniemi I, Mikkolainen K, Ranimo J, Lauharanta J. 2001 Transfusion practice in Helsinki University Hospital: An analysis of diagnosis-related groups (DRG). Transfus Med. 11: 423431.Google Scholar
Vamvakas E, Carven JH. 1998 Allogeneic blood transfusion, hospital charges, and length of hospitalization. Arch Pathol Lab Med. 122: 145151.Google Scholar